Exagen, Inc. (XGN)
8.56
+0.14
(+1.66%)
USD |
NASDAQ |
Oct 15, 16:00
8.54
-0.02
(-0.23%)
After-Hours: 20:00
Exagen Cash from Operations (TTM) : -6.498M for June 30, 2026
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -6.498M |
| March 31, 2026 | -13.37M |
| December 31, 2025 | -13.62M |
| September 30, 2025 | -10.25M |
| June 30, 2025 | -15.37M |
| March 31, 2025 | -14.91M |
| December 31, 2024 | -13.28M |
| September 30, 2024 | -5.293M |
| June 30, 2024 | -6.025M |
| March 31, 2024 | -13.75M |
| December 31, 2023 | -14.46M |
| September 30, 2023 | -28.54M |
| June 30, 2023 | -32.32M |
| March 31, 2023 | -33.32M |
| December 31, 2022 | -32.14M |
| September 30, 2022 | -32.46M |
| June 30, 2022 | -31.24M |
| March 31, 2022 | -24.53M |
| December 31, 2021 | -20.27M |
| September 30, 2021 | -18.12M |
| June 30, 2021 | -14.79M |
| March 31, 2021 | -15.10M |
| December 31, 2020 | -14.08M |
| September 30, 2020 | -14.11M |
| June 30, 2020 | -13.65M |
| Date | Value |
|---|---|
| March 31, 2020 | -11.06M |
| December 31, 2019 | -9.711M |
| September 30, 2019 | -7.653M |
| June 30, 2019 | -8.011M |
| March 31, 2019 | -7.821M |
| December 31, 2018 | -9.301M |
| September 30, 2018 | |
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 | |
| September 30, 2017 | |
| June 30, 2017 | |
| March 31, 2017 | |
| December 31, 2016 | |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | -11.90M |
| September 30, 2015 | -10.97M |
| June 30, 2015 | -10.45M |
| March 31, 2015 | -10.35M |
| December 31, 2014 | -10.77M |
| September 30, 2014 | -10.60M |
| June 30, 2014 | -9.651M |
| March 31, 2014 | -8.284M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Myriad Genetics, Inc. | 7.70M |
| BioRestorative Therapies, Inc. | -11.82M |
| CareDx, Inc. | 93.66M |
| Natera, Inc. | 228.24M |
| Sera Prognostics, Inc. | -27.68M |